SmartPhone-Based Fitness and mHealth Device Users to Approach 100 Million by 2018
The next 5 years will see a major shift towards smartphone-based mHealth, where hardware attachments link to companion app on the smartphone, a new report from Juniper Research has found.
The report, "Mobile Health & Fitness: Monitoring, App-Enabled Devices & Cost Savings 2013–2018" forecasts that by 2018 there will be 96 million users of app-enabled mHealth and mobile-fitness hardware devices, up from 15 million this year. In the healthcare sector, App-enabled mHealth will be used to enable services ranging from remote patient monitoring to mobile ultrasound services.
mFitness to Set Pace
The report, however, found that it will be the mFitness sector that will experience strongest growth in the short and medium term. According to the report, this growth will be driven by a motivated target market, an increasing demand for lifestyle consumer applications and a diversifying array of attachments. App-enabled mFitness will therefore reach maturity much more quickly than smartphone-based mHealth, though it ultimately represents a much smaller market in terms of both users and revenues.
Importantly, it will also serve to educate the wider market as to what is possible through smartphone attachments: “As mobile fitness devices become more widespread, they will pave the way for more critical mHealth services delivered through the smartphone,” says the report’s author Anthony Cox. “While mHealth and mobile fitness are two discrete markets — with divergent audiences — increased usage of the former will stimulate wider awareness of the latter”
Further findings from the report include
• Juniper Research forecasts cumulative cost savings from remote patient monitoring of up to 35 billion USD during the next 5 years as the healthcare industry moves towards accountable care.
• Well-documented trials illustrating both health and cost-benefits crucial to convince stakeholders of the value of mHealth.
• Ageing populations and the increased prevalence of chronic disease is forcing healthcare stakeholders to reconsider how healthcare is addressed in both developing and developed markets.
The whitepaper, "Mobilising Healthcare", and further details of the full study "Mobile Health & Fitness: Monitoring, App-enabled Devices & Cost Savings 2013–2018" can be downloaded from www.juniperresearch.com
Juniper Research provides research and analytical services to the global hi-tech communications sector, providing consultancy, analyst reports and industry commentary.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance